Chemical Structure : CAPCA-1
货号: PC-25193Not For Human Use, Lab Use Only.
CAPCA-1 (Cpmpound B) a highly potent cap-dependent endonuclease (CEN) inhibitor, shows broad-spectrum antiviral activity against bunyavirus including Lassa virus (LASV), lymphocytic choriomeningitis virus (LCMV), and Influenza viruses.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CAPCA-1 (Cpmpound B) a highly potent cap-dependent endonuclease (CEN) inhibitor, shows broad-spectrum antiviral activity against bunyavirus including Lassa virus (LASV), lymphocytic choriomeningitis virus (LCMV), and Influenza viruses.
CAPCA-1 inhibited LACV-induced CPE in a noncytotoxic range in a dose-dependent manner, with an EC50 value of 0.45 µM in CPE-based assays.
CAPCA-1 inhibits LACV-induced cell death at lower concentrations than the other CEN inhibitors.
CAPCA-1 reduced the LACV-induced CPE and viral growth in SH-SY5Y with EC50 of 0.69 uM.
CAPCA-1 disrupts the post-entry phase of LACV infection.
CAPCA-1 reduces the LACV burden and protects mice from lethal LACV infection.
CAPCA-1 is 100- to 1,000-fold more active in vitro than ribavirin against bunyaviruses, including Lassa virus, lymphocytic choriomeningitis virus (LCMV), and Junin virus.
分子量 | 459.50 | |
分子式 | C26H25N3O5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Toba S, et al. Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2206104119.
2. Konishi K, et al. Antimicrob Agents Chemother. 2025 Jul 23:e0018625.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright